High-resolution HLA typing by sequencing for HLA-A, -B, -C, -DR, -DQ in 122 unrelated cord blood/patient pair transplants hardly improves long-term clinical outcome

Bone Marrow Transplantation

Volumn 36, Issue 12, 2005, Pages 1033-1041

  Kogler G ^a   Enczmann, J ^a   Rocha, V ^b   Gluckman, E ^b   Wernet, P ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

HLA class I and II sequencing; Unrelated cord blood transplantation

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DNA; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQ ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; METHOTREXATE; PREDNISONE; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DNA SEQUENCE; FEMALE; HEMATOLOGIC DISEASE; HLA TYPING; HUMAN; INCIDENCE; INFANT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MISMATCH REPAIR; NEUTROPHIL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; TREATMENT OUTCOME; UMBILICAL CORD BLOOD; WHOLE BODY RADIATION;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS; FEMALE; FETAL BLOOD; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELLS; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-C ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; INFANT; MALE; MIDDLE AGED; NEUTROPHILS; TIME FACTORS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 30544453733     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705189     Document Type: Article

References (18)

1. Petersdorf EW, Gooley TA, Anasetti C et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 1998; 92: 3515-3520.
2. Giebel S, Giorgiani G, Martinetti M et al. Low incidence of severe acute graft-versus-host disease in children given haematopoietic stem cell transplantation from unrelated donors prospectively matched for HLA class I and II alleles with high-resolution molecular typing. Bone Marrow Transplant 2003; 31: 987-993.
3. Flomenberg N, Baxter-Lowe LA, Confer D et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 2004; 104: 1923-1930.
4. Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors [see comments]. N Engl J Med 1998; 339: 1565-1577.
5. Locatelli F, Rocha V, Chastang C et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group. Blood 1999; 93: 3662-3671.
6. Rocha V, Cornish J, Sievers EL et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97: 2962-2971.
7. Gluckman E, Rocha V, Arcese W et al. Factors associated with outcomes of unrelated cord blood transplant: Guidelines for donor choice. Exp Hematol 2004; 32: 397-407.
8. Gluckman E, Rocha V, Boyer Chammard A et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997; 337: 373-381.
9. Ottinger HD, Ferencik S, Beelen DW et al. Hematopoietic stem cell transplantation: Contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors. Blood 2003; 102: 1131-1137.
10. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
11. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Stat Med 1999; 18: 695-706.
12. Mickelson EM, Petersdorf EW, Hansen JA. HLA matching and hematopoietic cell transplant outcome. Clin Transplant 2002, 263-271.
13. Wagner JE, Barker JN, DeFor TE et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: Influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611-1618.
14. Sorg RV, Kogler G, Wernet P. Identification of cord blood dendritic cells as an immature CD11c negative population. Blood 1999; 93: 2302-2307.
15. Cohen SB, Perez Cruz I, Fallen P et al. Analysis of the cytokine production by cord and adult blood. Hum Immunol 1999; 60: 331-336.
16. Eskdale J, Gallagher G, Verweij CL et al. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA 1998; 95: 9465-9470.
17. Rubinstein P, Stevens CE. Placental blood for bone marrow replacement: the New York Blood Center's program and clinical results. Baillieres Best Pract Res Clin Haematol 2000; 13: 565-584.
18. Petersdorf EW, Longton GM, Anasetti C et al. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood 1997; 89: 1818-1823.